FDA nod for Novavax Covid vax, with stricter new conditions
The FDA has approved the Novavax Covid-19 vaccine, but with restrictions, limiting its use to older adults and those over 12 with high-risk medical conditions. This decision follows debates among CDC advisors about targeting Covid shots to the most vulnerable. The new limitations signal a potentially more restrictive approach from the FDA, influenced by skepticism towards vaccines.
The FDA has approved the Novavax Covid-19 vaccine, but with restrictions, limiting its use to older adults and those over 12 with high-risk medical conditions. This decision follows debates among CDC advisors about targeting Covid shots to the most vulnerable. The new limitations signal a potentially more restrictive approach from the FDA, influenced by skepticism towards vaccines. What's Your Reaction?
